Two Sigma Advisers’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
124,900
-72,100
| -37% | -$592K | ﹤0.01% | 1432 |
|
|
2025
Q1 | $1.41M | Buy |
197,000
+17,000
| +9% | +$122K | ﹤0.01% | 1298 |
|
|
2024
Q4 | $1.39M | Buy |
180,000
+112,000
| +165% | +$866K | ﹤0.01% | 1298 |
|
|
2024
Q3 | $713K | Sell |
68,000
-7,900
| -10% | -$82.9K | ﹤0.01% | 1557 |
|
|
2024
Q2 | $888K | Buy |
75,900
+18,700
| +33% | +$219K | ﹤0.01% | 1606 |
|
|
2024
Q1 | $1.21M | Buy |
57,200
+44,600
| +354% | +$940K | ﹤0.01% | 1486 |
|
|
2023
Q4 | $226K | Buy |
+12,600
| New | +$226K | ﹤0.01% | 2191 |
|
|
2023
Q2 | – | Sell |
-10,600
| Closed | -$200K | – | 2611 |
|
|
2023
Q1 | $200K | Sell |
10,600
-2,500
| -19% | -$47.3K | ﹤0.01% | 2268 |
|
|
2022
Q4 | $297K | Sell |
13,100
-8,300
| -39% | -$188K | ﹤0.01% | 2075 |
|
|
2022
Q3 | $566K | Buy |
21,400
+4,100
| +24% | +$108K | ﹤0.01% | 1791 |
|
|
2022
Q2 | $427K | Buy |
17,300
+4,100
| +31% | +$101K | ﹤0.01% | 1988 |
|
|
2022
Q1 | $438K | Buy |
+13,200
| New | +$438K | ﹤0.01% | 2049 |
|
|
2021
Q4 | – | Sell |
-53,000
| Closed | -$2.22M | – | 2777 |
|
|
2021
Q3 | $2.22M | Buy |
53,000
+40,700
| +331% | +$1.71M | 0.01% | 1190 |
|
|
2021
Q2 | $478K | Sell |
12,300
-27,500
| -69% | -$1.07M | ﹤0.01% | 1958 |
|
|
2021
Q1 | $1.36M | Buy |
+39,800
| New | +$1.36M | ﹤0.01% | 1475 |
|
|
2019
Q3 | – | Sell |
-35,900
| Closed | -$1.84M | – | 2366 |
|
|
2019
Q2 | $1.84M | Sell |
35,900
-53,800
| -60% | -$2.76M | ﹤0.01% | 1243 |
|
|
2019
Q1 | $5.14M | Sell |
89,700
-46,800
| -34% | -$2.68M | 0.01% | 832 |
|
|
2018
Q4 | $5.73M | Buy |
136,500
+2,800
| +2% | +$117K | 0.02% | 760 |
|
|
2018
Q3 | $10.1M | Buy |
133,700
+123,600
| +1,224% | +$9.33M | 0.02% | 577 |
|
|
2018
Q2 | $725K | Sell |
10,100
-8,400
| -45% | -$603K | ﹤0.01% | 1755 |
|
|
2018
Q1 | $552K | Sell |
18,500
-3,576
| -16% | -$107K | ﹤0.01% | 1775 |
|
|
2017
Q4 | $734K | Buy |
+22,076
| New | +$734K | ﹤0.01% | 1634 |
|